×
+ All Categories
Log in
English
Français
Español
Deutsch
The top documents tagged [treatment interruptions]
Home >
treatment interruptions
Education of patients taking capecitabine EORTC 10041 BIG 3-04 Intergroup Study MINDACT (Microarray In Node-negative Disease may Avoid ChemoTherapy): A.
215 views
Www.ias2013.org Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Access to HCV triple therapy with Telaprevir or Boceprevir in a real-life setting in HIV-HCV.
214 views
Loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi: Understanding outcomes and reasons Hannock Tweya, Salem Gugsa, Mina Hosseinipour,
216 views
Gary Hampton - Aids Dementia & HIV Psychiatry Service - SESSION 1: Breaking Out: HIV Treatment and Care when PLWHIV (People Living with HIV) Transition from Custodial Settings into
382 views
Profesional natalizumab benefit risk update may 2013
14.014 views
Natalizumb benefit risk update August 2013
2.964 views
Natalizumab safety and pml risk stratification march 2013
51.120 views
Tysabri benefit risk update july 2013 (ty-pan-0597(2))
2.752 views
Natalizumab benefit risk update january 2014
3.268 views
Natalizumab Safety Update September 2012
2.649 views
Natalizumab benefit risk update November 2013
4.492 views
Tysabri safety and pml risk stratification ty pan-0463s october giovannoni gg1
1.153 views
Next >